The global market for Biopreservation was estimated at US$2.9 Billion in 2025 and is projected to reach US$9.1 Billion by 2032, growing at a CAGR of 17.6% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The application of biopreservation is particularly noteworthy in biobanking and regenerative medicine, sectors that heavily rely on these technologies for stem cell preservation and the manufacturing of cell therapies compliant with Good Manufacturing Practices (GMP). Biopreservation supports the intricate requirements of maintaining 'living drugs' through their lifecycle, optimizing preservation media to meet regulatory standards and ensure successful commercialization. This is crucial in regenerative medicine where the viability of cell therapies must be maintained from collection through to administration. Moreover, low-temperature storage methods, like cryogenic and hypothermic storage, play a pivotal role in this regard by reducing metabolic rates and minimizing biochemical requirements, which is vital for preserving cellular function and integrity during storage.
Several growth drivers are propelling the biopreservation market, including technological advancements that improve the efficiency of biological material storage, the expansion of R&D in biotechnology and medicine, and the increasing prevalence of chronic diseases that necessitate advanced therapeutic solutions. The expansion of biobanks globally, which requires robust biopreservation to maintain the integrity of biological samples, along with significant governmental and private funding, further fuels this growth. Additionally, stringent regulatory requirements necessitate reliable biopreservation solutions to ensure that biologically derived therapeutic products are safe and effective for clinical use. Innovations like improved cryopreservation technologies and novel media formulations that enhance cell viability and recovery rates are also crucial. As the field evolves, the integration of these technological advancements with increased healthcare investments underscores the crucial role of biopreservation in advancing healthcare and research, promising continued expansion and innovation in the preservation and utilization of vital biological resources.
Global Biopreservation Market - Key Trends and Drivers Summarized
Biopreservation technologies play a crucial role in extending the functional lifespan of biological materials such as cells, tissues, and organs, essential for a broad range of medical and scientific applications. This field has experienced significant growth due to advancements in preservation methods, increased government and private funding for healthcare research, and a rising demand across various medical and research sectors. Particularly beneficial in the realms of immunotherapies, vaccine production, and enzyme technology, biopreservation helps address the growing incidence of chronic diseases by maintaining the viability and functionality of biological materials. Furthermore, the technology incorporates sophisticated tools like microarrays and predictive models which streamline the preservation processes, enhancing diagnosis and treatment capabilities, especially in critical areas such as cardiology and gynecology.The application of biopreservation is particularly noteworthy in biobanking and regenerative medicine, sectors that heavily rely on these technologies for stem cell preservation and the manufacturing of cell therapies compliant with Good Manufacturing Practices (GMP). Biopreservation supports the intricate requirements of maintaining 'living drugs' through their lifecycle, optimizing preservation media to meet regulatory standards and ensure successful commercialization. This is crucial in regenerative medicine where the viability of cell therapies must be maintained from collection through to administration. Moreover, low-temperature storage methods, like cryogenic and hypothermic storage, play a pivotal role in this regard by reducing metabolic rates and minimizing biochemical requirements, which is vital for preserving cellular function and integrity during storage.
Several growth drivers are propelling the biopreservation market, including technological advancements that improve the efficiency of biological material storage, the expansion of R&D in biotechnology and medicine, and the increasing prevalence of chronic diseases that necessitate advanced therapeutic solutions. The expansion of biobanks globally, which requires robust biopreservation to maintain the integrity of biological samples, along with significant governmental and private funding, further fuels this growth. Additionally, stringent regulatory requirements necessitate reliable biopreservation solutions to ensure that biologically derived therapeutic products are safe and effective for clinical use. Innovations like improved cryopreservation technologies and novel media formulations that enhance cell viability and recovery rates are also crucial. As the field evolves, the integration of these technological advancements with increased healthcare investments underscores the crucial role of biopreservation in advancing healthcare and research, promising continued expansion and innovation in the preservation and utilization of vital biological resources.
Report Scope
The report analyzes the Biopreservation market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:- Segments: Product Type (Biopreservation Media, Biopreservation Equipment); Biospecimen (Human Tissue Samples, Organs, Stem Cells, Other Biospecimens); Application (Therapeutic Applications, Research Applications, Clinical Trials, Other Applications); End-Use (Biobanks, Gene Banks, Hospitals, Other End-Uses).
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Equipment Offering segment, which is expected to reach US$4.6 Billion by 2032 with a CAGR of 19.3%. The Media Offering segment is also set to grow at 16.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $904.0 Million in 2025, and China, forecasted to grow at an impressive 23.7% CAGR to reach $2.5 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Biopreservation Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biopreservation Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Biopreservation Market expected to evolve by 2032?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2032?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Atlanta Biologicals, Inc., BioCision, LLC, BioGenix, LLC, BioLife Solutions, Inc., Biomatrica, Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the companies featured in this Biopreservation market report include:
- Atlanta Biologicals, Inc.
- BioCision, LLC
- BioGenix, LLC
- BioLife Solutions, Inc.
- Biomatrica, Inc.
- LabVantage Solutions, Inc.
- Panasonic Corporation
- Qiagen, Inc.
- Thermo Fisher Scientific, Inc.
- VWR International LLC
Domain Expert Insights
This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 1,702 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Atlanta Biologicals, Inc.
- BioCision, LLC
- BioGenix, LLC
- BioLife Solutions, Inc.
- Biomatrica, Inc.
- LabVantage Solutions, Inc.
- Panasonic Corporation
- Qiagen, Inc.
- Thermo Fisher Scientific, Inc.
- VWR International LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 259 |
| Published | May 2026 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 2.9 Billion |
| Forecasted Market Value ( USD | $ 9.1 Billion |
| Compound Annual Growth Rate | 17.6% |
| Regions Covered | Global |
